Hemodynamic and Perfusion Response to Drotrecogin Alfa (Activated) in Patients With Septic Shock
Clinical trial NCT00279214 · COMPLETED
Trial details
- NCT number
- NCT00279214
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.